NYSE:CHEHealthcare
Chemed (CHE) Net Margin Decline Tests Bullish Efficiency And Growth Narratives
Chemed (CHE) opened Q1 2026 with revenue of US$657.5 million and basic EPS of US$4.85, while trailing twelve month figures show revenue of US$2.5b and basic EPS of US$18.34. Over the past year, revenue has ranged from US$618.8 million to US$646.9 million in the 2025 quarters, with basic EPS moving between US$3.60 and US$5.48 across the same periods. This gives investors a clear view of how the current print fits into a steady recent run. With net profit margin at 10.2% over the trailing...